OCX - Oncocyte Corp - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - In Vitro & In Vivo Diagnostic Substances - OCX (1642380)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
18 results - Yahoo - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2020-08-03
OCXParker Albert PCOOP - Purchase$1.33+5,0005,000New+$6,648
2020-08-03
OCXKalajian Tony TSr.VP, Chief Accounting OfficeP - Purchase$1.31+5,00015,000+50%+$6,533
2020-08-03
OCXAndrews Ronald AsburyCEOP - Purchase$1.35+40,000102,698+64%+$53,880
2020-08-03
OCXLevine Mitchell SCFOP - Purchase$1.32+10,00036,579+38%+$13,200
2020-04-24
OCXBroadwood Partners, L.P.10%P - Purchase$2.27+1,050,00029,435,553+4%+$2,383,500
AM
2020-03-30
OCXAndrews Ronald AsburyCEO, PresP - Purchase$2.30+45,21662,698+259%+$104,150
EM
2020-03-30
OCXAndrews Ronald AsburyCEO, PresP - Purchase$1.41+45,21662,698+259%+$63,826
2020-01-02
OCXBroadwood Partners, L.P.10%P - Purchase$2.16+1,391,46627,335,553+5%+$3,000,001
2020-01-02
OCXLineage Cell Therapeutics, Inc.Previous 10% OwnerS - Sale$2.16-2,383,0906,041,154-28%-$5,137,942
2019-11-13
OCXBroadwood Partners, L.P.10%P - Purchase$1.70+1,176,47124,552,621+5%+$2,000,001
2019-09-17
OCXArno AndrewDirP - Purchase$2.16+50,000102,447+95%+$108,130
2019-09-13
OCXKalajian Tony TSVP-Chief Accounting OfficerP - Purchase$1.98+10,00010,000New+$19,800
2019-09-11
OCXLineage Cell Therapeutics, Inc.10%S - Sale$1.66-4,000,0008,424,244-32%-$6,640,000
2019-09-11
OCXBroadwood Partners, L.P.10%P - Purchase$1.66+2,000,00022,199,679+10%+$3,320,000
2019-09-12
OCXLevine Mitchell SCFOP - Purchase$2.01+10,00010,000New+$20,060
2019-07-05
OCXBiotime Inc10%S - Sale$2.00-2,250,00012,424,244-15%-$4,500,000
2019-07-02
OCXBroadwood Partners, L.P.10%P - Purchase$2.00+1,000,00018,199,679+6%+$2,000,000
2019-02-08
OCXBroadwood Partners, L.P.10%P - Purchase$3.75+533,33316,199,679+3%+$1,999,999
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top